Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Gastaldon

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
The Lancet. Child & Adolescent Health|September 30, 2023
The WHO Model List of Essential Medicines for Children needs its own identity: the case of psychotropic medicinesDavide Papola, Giovanni Ostuzzi, Chiara Gastaldon, et al.
Epidemiology and Psychiatric Sciences|May 11, 2022
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countriesGiovanni Ostuzzi, Chiara Gastaldon, Davide Papola, et al.
Epidemiology and Psychiatric Sciences|May 7, 2020
Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countriesGiovanni Ostuzzi, Chiara Gastaldon, Carlo Petrini, et al.
Archives of Public Health = Archives Belges De Sante Publique|January 18, 2023
Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendationsBeatrice Todesco, Giovanni Ostuzzi, Chiara Gastaldon, et al.
Epidemiology and Psychiatric Sciences|February 1, 2024
Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countriesCorrado Barbui, Davide Papola, Beatrice Todesco, et al.
JAMA Network Open|August 20, 2024
Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and SuicidalityGeorgios Schoretsanitis, Stefan Weiler, Corrado Barbui, et al.
Psychotherapy and Psychosomatics|August 28, 2020
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting SystemChiara Gastaldon, Emanuel Raschi, John M Kane, et al.
Psychotherapy and Psychosomatics|October 22, 2020
Reply to the Comments by Doherty et alChiara Gastaldon, Emanuel Raschi, John M Kane, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 27, 2022
Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studiesChiara Gastaldon, Marco Solmi, Christoph U Correll, et al.
Human Reproduction Open|May 21, 2026
Comparative effect of different surgical treatments for ovarian endometrioma on anti-Müllerian hormone levels: a systematic review and network meta-analysisKonstantinos Nirgianakis, Dimitrios Rafail Kalaitzopoulos, Nikolaus Fadinger, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
The Lancet. Child & Adolescent Health|September 30, 2023
The WHO Model List of Essential Medicines for Children needs its own identity: the case of psychotropic medicinesDavide Papola, Giovanni Ostuzzi, Chiara Gastaldon, et al.
Epidemiology and Psychiatric Sciences|May 11, 2022
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countriesGiovanni Ostuzzi, Chiara Gastaldon, Davide Papola, et al.
Epidemiology and Psychiatric Sciences|May 7, 2020
Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countriesGiovanni Ostuzzi, Chiara Gastaldon, Carlo Petrini, et al.
Archives of Public Health = Archives Belges De Sante Publique|January 18, 2023
Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendationsBeatrice Todesco, Giovanni Ostuzzi, Chiara Gastaldon, et al.
Epidemiology and Psychiatric Sciences|February 1, 2024
Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countriesCorrado Barbui, Davide Papola, Beatrice Todesco, et al.
JAMA Network Open|August 20, 2024
Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and SuicidalityGeorgios Schoretsanitis, Stefan Weiler, Corrado Barbui, et al.
Psychotherapy and Psychosomatics|August 28, 2020
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting SystemChiara Gastaldon, Emanuel Raschi, John M Kane, et al.
Psychotherapy and Psychosomatics|October 22, 2020
Reply to the Comments by Doherty et alChiara Gastaldon, Emanuel Raschi, John M Kane, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 27, 2022
Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studiesChiara Gastaldon, Marco Solmi, Christoph U Correll, et al.
Human Reproduction Open|May 21, 2026
Comparative effect of different surgical treatments for ovarian endometrioma on anti-Müllerian hormone levels: a systematic review and network meta-analysisKonstantinos Nirgianakis, Dimitrios Rafail Kalaitzopoulos, Nikolaus Fadinger, et al.
Pageof 6